Fractyl Health (GUTS) Asset Utilization Ratio (2024)

Name: Fractyl Health (GUTS) Asset Utilization Ratio (2024) | Business Quant
Creator: Business Quant

Fractyl Health (GUTS) reported Asset Utilization Ratio of 0.0 for Q4 2024, up 11.53% quarter-over-quarter from 0.0 in Q3 2024.

Fractyl Health (GUTS) has 1 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2024.

For the quarter ending Q4 2024, Asset Utilization Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Dec 2024 stood at 0.0 (changed N/A YoY), and the FY2024 full-year result was 0.0, changed N/A from the prior year.
Asset Utilization Ratio for Q4 2024 stood at 0.0, up from 0.0 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.0 in Q1 2024 and bottomed at 0.0 in Q3 2024.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Quantum Biopharma	1,638,563.89 Bn	1,638,563.89 Bn	-	-
2	Alterity Therapeutics	767,934.24 Bn	767,934.20 Bn	-	-
3	Legend Biotech	2,937.00 Bn	2,936.10 Bn	242.10 Mn	0.60
4	Nanobiotix	2,226.01 Bn	2,225.95 Bn	-	-
5	Akari Therapeutics	2,169.69 Bn	2,169.69 Bn	-	-
6	Vertex Pharmaceuticals	110.41 Bn	103.16 Bn	2.59 Bn	0.47
7	Regeneron Pharmaceuticals	66.44 Bn	57.69 Bn	3.31 Bn	0.37
8	Evaxion A	65.44 Bn	65.42 Bn	-	0.29
9	Alnylam Pharmaceuticals	39.53 Bn	36.52 Bn	959.66 Mn	0.85
10	Fractyl Health	19.24 Mn	19.24 Mn	-	-

Download Data 🔒